Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDO INTERNATIONAL PLC ENDPQ

Healthcare Drug Manufacturers - Specialty & Generic
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Recent & Breaking News (GREY:ENDPQ)

Endo Presents New Investigational Collagenase Clostridium Histolyticum (CCH) Survey Data at American Society for Surgery of the Hand (ASSH) Annual Meeting

PR Newswire September 30, 2021

Endo Reaches Agreement in Principle to Settle Louisiana Governmental Opioid Cases and Claims

PR Newswire September 28, 2021

Endo Launches First and Only Generic Version of Chantix® (varenicline) Tablets in the United States

PR Newswire September 22, 2021

Endo Settles New York State Opioid Cases and Provides Update on Remaining Opioid Litigation

PR Newswire September 9, 2021

Endo Comments on Non-Infringement Ruling in VASOSTRICT® Patent Litigation

PR Newswire August 31, 2021

Endo Reports Second-Quarter 2021 Financial Results And Updates 2021 Financial Guidance

PR Newswire August 5, 2021

Endo Announces Execution of Definitive Settlement Agreement and Release Resolving Tennessee State Court Case

PR Newswire August 4, 2021

Endo Presents New Investigational Collagenase Clostridium Histolyticum Data at the American Podiatric Medical Association Annual Scientific Meeting

PR Newswire July 29, 2021

Endo Announces Agreement in Principle to Settle Tennessee State Court Case

PR Newswire July 22, 2021

Endo Comments on Tennessee Appeals Court Orders

PR Newswire July 15, 2021

Endo to Announce Second Quarter 2021 Financial Results

Canada NewsWire June 24, 2021

Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at Cosmetic Bootcamp 2021

Canada NewsWire June 24, 2021

Tennessee Court Of Appeals Issues Orders Regarding State Court Default Judgment Against Endo

Canada NewsWire June 11, 2021

Paladin Labs Inc. Announces Approval of Wakix® (pitolisant) in Canada

Canada NewsWire June 9, 2021

Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance

Canada NewsWire May 6, 2021

Maverix Private Equity Announces Team Additions

Canada NewsWire May 3, 2021

Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at The Aesthetic Meeting 2021

Canada NewsWire April 29, 2021

Endo Implements Board Succession Plan

Canada NewsWire April 27, 2021

Endo to Announce First Quarter 2021 Financial Results

Canada NewsWire April 13, 2021

Endo Announces Publication of Phase 3 Qwo® (collagenase clostridium histolyticum-aaes) Data in Peer-Reviewed Dermatologic Surgery

Canada NewsWire April 13, 2021